Nisoldipine

尼索地平

Report date: 2026/04/16 20:00:17
NME

Base Information

Drug NameNisoldipine
Drug Alias Namenisoldipinum尼素地平nisoldipine尼索的平nisoldipino +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryUnited States
Original Approved Date1995/02/02
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShionogi & Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAzurity Pharmaceuticals IncJiangsu Sihuan Bioengineering Co Ltd
Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC08CA07
Related LinksWikipediaDrugBankKEGG